Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.

Rakha EA, Tun M, Junainah E, Ellis IO, Green A.

J Clin Pathol. 2012 Aug;65(8):710-4. doi: 10.1136/jclinpath-2012-200710. Epub 2012 May 3.

PMID:
22554960
[PubMed - indexed for MEDLINE]
2.

Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.

Rahko E, Kauppila S, Pääkkö P, Blanco G, Apaja-Sarkkinen M, Talvensaari-Mattila A, Turpeenniemi-Hujanen T, Jukkola A.

Tumour Biol. 2009;30(5-6):257-64. doi: 10.1159/000253662. Epub 2009 Oct 31.

PMID:
19887890
[PubMed - indexed for MEDLINE]
3.

Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.

Esposito NN, Dabbs DJ, Bhargava R.

Am J Clin Pathol. 2009 Feb;131(2):228-42. doi: 10.1309/AJCP8A2UVLCYGTPU.

PMID:
19141383
[PubMed - indexed for MEDLINE]
Free Article
4.

Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.

Zhang YG, DU J, Tian XX, Zhong YF, Fang WG.

Chin Med J (Engl). 2007 Sep 20;120(18):1597-605.

PMID:
17908479
[PubMed - indexed for MEDLINE]
5.

Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.

Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.

Clin Cancer Res. 1999 May;5(5):1041-56.

PMID:
10353737
[PubMed - indexed for MEDLINE]
Free Article
6.

Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.

Rakha EA, Gandhi N, Climent F, van Deurzen CH, Haider SA, Dunk L, Lee AH, Macmillan D, Ellis IO.

Am J Surg Pathol. 2011 Aug;35(8):1093-103. doi: 10.1097/PAS.0b013e31821b3f65.

PMID:
21753694
[PubMed - indexed for MEDLINE]
7.

Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.

Brummer O, Athar S, Riethdorf L, Löning T, Herbst H.

Virchows Arch. 1999 Dec;435(6):566-73.

PMID:
10628798
[PubMed - indexed for MEDLINE]
8.

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.

Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG.

Mod Pathol. 2007 Jan;20(1):84-9. Epub 2006 Nov 24.

PMID:
17143263
[PubMed - indexed for MEDLINE]
Free Article
9.

Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.

Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ.

Am J Surg Pathol. 2006 Aug;30(8):1002-7.

PMID:
16861972
[PubMed - indexed for MEDLINE]
10.

Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.

Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, Isaka K, Saarialho-Kere U.

J Pathol. 2004 Jan;202(1):14-22.

PMID:
14694517
[PubMed - indexed for MEDLINE]
11.

Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.

Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.

Breast Cancer Res Treat. 2010 Sep;123(2):397-404. doi: 10.1007/s10549-009-0654-0. Epub 2009 Dec 1.

PMID:
19949854
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.

González LO, González-Reyes S, Junquera S, Marín L, González L, Del Casar JM, González JM, Vizoso F.

J Cancer Res Clin Oncol. 2010 Sep;136(9):1313-21. doi: 10.1007/s00432-010-0782-2. Epub 2010 Feb 3.

PMID:
20127359
[PubMed - indexed for MEDLINE]
13.

Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.

Dalberg K, Eriksson E, Enberg U, Kjellman M, Bäckdahl M.

World J Surg. 2000 Mar;24(3):334-40.

PMID:
10658069
[PubMed - indexed for MEDLINE]
14.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
[PubMed - indexed for MEDLINE]
15.

Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.

Ottesen GL.

APMIS Suppl. 2003;(108):1-67. Review.

PMID:
12874968
[PubMed - indexed for MEDLINE]
16.

Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.

Nielsen BS, Rank F, López JM, Balbin M, Vizoso F, Lund LR, Danø K, López-Otín C.

Cancer Res. 2001 Oct 1;61(19):7091-100.

PMID:
11585740
[PubMed - indexed for MEDLINE]
Free Article
17.

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.

Okumura Y, Yamamoto Y, Zhang Z, Toyama T, Kawasoe T, Ibusuki M, Honda Y, Iyama K, Yamashita H, Iwase H.

BMC Cancer. 2008 Oct 6;8:287. doi: 10.1186/1471-2407-8-287.

PMID:
18837981
[PubMed - indexed for MEDLINE]
Free PMC Article
18.
19.

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.

Wärnberg F, Nordgren H, Bergkvist L, Holmberg L.

Br J Cancer. 2001 Sep 14;85(6):869-74.

PMID:
11556839
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.

Farshid G, Moinfar F, Meredith DJ, Peiterse S, Tavassoli FA.

Virchows Arch. 2001 Jul;439(1):70-7.

PMID:
11499843
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk